Dr. Michael Amylon, MD
Palo Alto, CA
43 Years of Experience
Who is Dr. Amylon, Pediatric Hematologist-Oncologist in Palo Alto, CA?
Dr. Michael Amylon, MD is a Pediatric Hematologist-Oncologist, who primarily practices in Palo Alto, CA. He has been practicing for over 43 years and is board certified. Dr. Amylon graduated from Stanford University School of Medicine and completed his residency at Stanford Univ Hosp, Pediatric Hematology-Oncology; Stanford Univ Hosp, Pediatrics. Dr. Amylon is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Amylon’s office at (650) 497-8953.
What are Areas of Expertise for Dr. Amylon?
Dr. Michael Amylon, MD is a highly-rated, board-certified Pediatric Hematologist-Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Amylon empowers patients to confidently navigate their health journey, specializing in Leukemia & Lymphoma, Stem Cell Transplant, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Amylon is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Amylon go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine CA
Residency: Stanford Univ Hosp, Pediatric Hematology-Oncology; Stanford Univ Hosp, Pediatrics | Stanford University Medical Center
Medical School: Stanford Univ Sch Of Med- Stanford Ca | Stanford University School of Medicine
Is Dr. Amylon board certified as a Pediatric Hematologist-Oncologist?
Yes, Dr. Michael Amylon, MD is board certified by the American Board of Pediatrics , American Board of Dermatology since 1982, American Board of Pediatrics since 1980
What languages does Dr. Amylon speak?
Dr. Amylon and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Pediatric Hematologist-Oncologist like Dr. Amylon typically treat?
As a Pediatric Hematologist-Oncologist, conditions treated by Dr. Michael Amylon may include:
Please contact Dr. Amylon's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Pediatric Hematologist-Oncologist like Dr. Amylon typically perform?
As a Pediatric Hematologist-Oncologist, procedures performed by Dr. Michael Amylon may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
Please contact Dr. Amylon's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Amylon accept my insurance?
Please contact Dr. Amylon's office to confirm accepted insurance plans.
Where is Dr. Amylon's office located?
Recognitions
Publications
SAFETY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN LESS THAN THREE YEARS OF AGE
, 2008
Projective drawings as measures of psychosocial functioning
, 2008
Hematopoietic stem cell transplantation after first marrow relapse of non-T
, 2006
Siblings of pediatric cancer patients: The quantitative and qualitative ture of quality of life
, 2005
High-dose therapy and autologous hematopoietic stem
, 2004
Camp Okizu: Prelimiry investigation of a psychological intervention for siblings of pediatric
, 2004
Allogeneic hematopoietic cell transplantation for patients with high
, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia
, 2003
High-dose therapy and autologous hematopoietic cell transplantation in children with primary
, 2001
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens
, 2000
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic
, 1999
Intensive high-dose asparagise consolidation improves survival for pediatric patients with T cell
, 1999
Cyclosporine, methotrexate
, 1999
Fractioted total-body irradiation, etoposide
, 1997
Allogeneic bone marrow transplant in pediatric patients with high
, 1997
Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia
, 2006
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.
, 2004
Development and testing of the School Competency Assessment Scale.
, 2003
Genetic polymorphisms in CYP3A5
, 2002
Bone marrow stroma-supported culture of T
, 2002
Relationship of p15
, 2001
New recurring cytogenetic abnormalities
, 2000
Slow disappearance of peripheral blood blasts is an adverse prognostic factor
, 2000
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia
, 2000
Cost alysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia
, 2000
Glutathione S-transferase genotypes in children who develop treatment
, 2000
Significance of commonly used prognostic factors differs
, 1999
Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants
, 1999
Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T
, 1999
Somatization, anxiety and depression as measures of health-related quality of life of children
, 1999
Randomized trial of r
, 1998
Bone marrow transplant in thalassemia - A role for radiation?
, 1998
Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B
, 1997
Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with P16
, 1997
Influence of age on the outcome of 500 autologous bone marrow transplant procedures
, 1997
Bone marrow transplant in thalassemia at Stanford University: A role for radiation?
, 1996
Influence of preparatory regimen
, 1996
Pleuropulmory blastoma: A marker for familial disease
, 1996
Identifying early predictors of mortality in pediatric patients with acute leukemia and pneumonia
, 1996
BUSULFAN/CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE
, 1995
DOES ACTIVATION OF THE TAL1 GENE OCCUR IN A MAJORITY OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC
, 1995
FRACTIOTED TOTAL-BODY IRRADIATION AND HIGH
, 1994
BONE-MARROW TRANSPLANTATION FOR THALASSEMIA - THE USA EXPERIENCE
, 1994
ROLE OF ETOPOSIDE (VP
, 1994
FRACTIOTED TOTAL-BODY IRRADIATION AND HIGH
, 1993
CYCLOSPORINE, METHOTREXATE
, 1993
HRX INVOLVEMENT IN DENOVO AND SECONDARY LEUKEMIAS WITH DIVERSE CHROMOSOME 11Q23 ABNORMALITIES
, 1993
MULTIFOCAL LEUKOENCEPHALITIS CAUSED BY VARICELLA-ZOSTER VIRUS IN A CHILD WITH LEUKEMIA
, 1993
CLINICAL-FEATURES AND OUTCOME OF T
, 1993
BUSULFAN ETOPOSIDE - INITIAL EXPERIENCE WITH A NEW PREPARATORY REGIMEN FOR AUTOLOGOUS BONE
, 1993
LANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VE-CAVA SYNDROME - A CASE-REPORT
, 1993
T(2-14)(P13-Q32) - A RECURRING ABNORMALITY IN LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP
, 1992
Allogeneic bone marrow transplantation for high
, 1991
ALLOGENEIC BONE-MARROW TRANSPLANTATION AS THERAPY FOR PRIMARY INDUCTION FAILURE FOR PATIENTS WITH
, 1991
PHILADELPHIA-CHROMOSOME AND MONOSOMY
, 1991
LACK OF TRANSMISSION OF THE LIVE ATTENUATED VARICELLA VACCINE VIRUS TO IMMUNOCOMPROMISED CHILDREN
, 1991
Dermatoglyphics and acute lymphocytic leukemia in children.
, 1991
TREATMENT OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
, 1990
THE T(1-14)(P34-Q11) IS NONRANDOM AND RESTRICTED TO T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A
, 1990
REPOPULATION OF MARROW AFTER TRANSPLANTATION - MR IMAGING WITH PATHOLOGICAL CORRELATION
, 1990
Bone marrow transplantation for hematologic maligncies: the Stanford experience.
, 1990
REDUCED NEUTROPHIL COUNTS IN CHILDREN WITH TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD
, 1989
AFTER TREATMENT ENDS - PSYCHOSOCIAL SEQUELAE IN PEDIATRIC CANCER SURVIVORS
, 1988
IDIOTYPE AS A TUMOR-SPECIFIC MARKER IN CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
, 1988
CLINICAL AND BIOLOGIC CHARACTERIZATION OF T-CELL NEOPLASIAS WITH REARRANGEMENTS OF CHROMOSOME
, 1988
ESTABLISHMENT AND CHARACTERIZATION OF A COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA CELL
, 1987
PREDNISONE STIMULATION OF ERYTHROPOIESIS IN LEUKEMIC CHILDREN DURING REMISSION
, 1986
INTENSIVE RETREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN 1ST BONE
, 1986
CHROMOSOME-9 ABNORMALITIES IN CHILDHOOD T-CELL LEUKEMIA
, 1986
VARICELLA ZOSTER ANTIBODY
, 1984
IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
, 1984
COMPARISON OF VARICELLA ZOSTER ANTIBODY
, 1984
CRANIAL NERVE INVOLVEMENT IN CHILDREN WITH LEUKEMIA AND LYMPHOMA
, 1983
A SINGLE MONOCLOL-ANTIBODY IDENTIFIES T-CELL LINEAGE OF CHILDHOOD LYMPHOID MALIGNCIES
, 1983
What is Dr. Amylon's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Amylon's National Provider Identifier (NPI) number is 1396931291.
What common questions do patients ask about Dr. Amylon?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Amylon
What is Dr. Michael Amylon's specialty?
Dr. Amylon is a Pediatric Hematologist-Oncologist near Palo Alto, CA.
What does a Pediatric Hematologist-Oncologist do?
A pediatrician trained in the integration of pediatrics, hematology, and oncology, specializing in the recognition and management of blood disorders and cancer in children. This expert provides comprehensive care for conditions such as anemia, bleeding disorders, and various pediatric cancers.
Is this Dr. Michael Amylon affiliated with a ranked Castle Connolly Top Hospital?
No, Amylon is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Stanford Medicine Children’s Health. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Pediatric Hematologist-Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Pediatric Hematologist-Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Michael Amylon accepting new patients in Palo Alto, CA?
Yes, Dr. Michael Amylon is accepting new patients at this time.
Does Dr. Michael Amylon offer online booking?
Please contact Dr. Amylon's office at (650) 497-8953 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Michael Amylon?
Please contact Dr. Amylon's office at (650) 497-8953 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Michael Amylon have?
Dr. Michael Amylon is certified by the American Board of Pediatrics and American Board of Dermatology.
Other Pediatric Hematologist-Oncologist Near Palo Alto, CA
Pediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patients